UbiVac
Glenna McDonnell is an experienced process development professional, currently serving as a Process Development Associate at UbiVac since April 2016. Prior positions include Process Development Associate II at DianaPlantSciences from April 2014 to January 2016, and Process Development Associate III at Maxygen/Perseid Therapeutics from 2008 to 2011. Earlier in the career, Glenna held roles as a Process Development Engineer I at Genitope from March 2006 to June 2008, a Research Assistant at Amgen from 2004 to 2006, and a Bioprocess Assistant at BD Biosciences from 2003 to 2004. Glenna McDonnell earned a Bachelor of Science degree in Bioengineering from UC San Diego, with studies completed between 1999 and 2003.
This person is not in any teams
This person is not in any offices
UbiVac
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. Founded in Portland, OR in 2005 as a spinout of the Robert W. Franz Cancer Research Center within the Earle A. Chiles Research Institute, at Providence Portland Medical Center, UbiVac continues to build upon thegroundbreaking research being developed in the region.